 LAKE FOREST, Calif.--BUSINESS WIRE--STAAR Surgical Company NASDAQ: STAA, a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye, today provided preliminary results for the fourth quarter and fiscal year ended January 1, 2021. The Company expects total net sales for the fourth quarter to be approximately 46 million and full year sales to be approximately 163 million. GAAP earnings per share is expected to be approximately 0.06 for t 